Tuesday, 16 February 2016

Engineered immune cells yield "unprecedented" results in early cancer trials

T-Cell therapy has delivered promising results in early trials involving patients with acute lymphoblastic leukemia

Removing immune cells, training them to attack cancer and then reintroducing them into the body has emerged as a promising approach to overcoming the deadly disease. And researchers are now reporting a significant advance in this area, with one early experiment on advanced blood cancer patients producing "unprecedented" response rates of more than 93 percent.

.. Continue Reading Engineered immune cells yield "unprecedented" results in early cancer trials

Category: Medical

Tags: Related Articles:

from Gizmag Emerging Technology Magazine http://ift.tt/1XwT9e1

No comments:

Post a Comment